Aether Bio
14 known investors
Aether (Aether Biomachines) is an AI company that uses a Protein Function Model and a robotic high-throughput screening lab to discover novel proteins and materials for industrial manufacturing, including reinforced nylon 3D-printing filaments and proteins for critical minerals processing. It serves defense, aerospace, and industrial manufacturing customers, with a stated focus on U.S. reindustrialization.
AI & Machine LearningBiotechNew Materials
Investors · 14
4DX VenturesAccra · $50K – $500K
Abstract VenturesSan Francisco · $250K – $750K
Artis VenturesSan Francisco · $50K – $25M
Blue Bear VenturesSan Francisco · $100K – $400K
BoxGroupNew York · $1M
Calm VenturesSan Franciscovia Zachary Ginsburg · inferred
Evolution VC PartnersNew York
Good AI CapitalMenlo Park
Modi VenturesHouston
UnlessBoulder
WorldQuant VenturesOld Greenwich
10x FoundersreportedMünchen · $270K – $2.7M
Dolby Family VenturesreportedSan Francisco
Refactor CapitalreportedBurlingame · $1M – $2M
Frequently asked questions
- What does Aether Bio do?
- Aether (Aether Biomachines) is an AI company that uses a Protein Function Model and a robotic high-throughput screening lab to discover novel proteins and materials for industrial manufacturing, including reinforced nylon 3D-printing filaments and proteins for critical minerals processing. It serves defense, aerospace, and industrial manufacturing customers, with a stated focus on U.S. reindustrialization.
- Who are Aether Bio's investors?
- Aether Bio's investors include 4DX Ventures, Abstract Ventures, Artis Ventures, Blue Bear Ventures, BoxGroup, Calm Ventures, Evolution VC Partners, Good AI Capital and 6 more.